Condition: Fragile X Syndrome · Metformin · Sponsor: Children's Hospital of Fudan University
This study is a controlled trial of metformin in children with fragile X syndrome(FXS). The age of FXS children range from 2 to 16 years old. Participants will be randomized in a double-blind design to either drug or placebo for 6-month period. The primary objectives are to assess metformin in treatment of behavior problems, cognitive and language with fragile X syndrome.
This description comes directly from the study's public registry record.
Qiong Xu, Phd MD · 862164931275 · stellaxuqiong@hotmail.com
Chunchun Hu, MD · 862164931275 · 14211240007@fudan.edu.com
Always discuss trial participation with your own doctor first.
| Children's Hospital of Fudan University | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05120505